Key Findings Researchers found a 1 % increase in
stage I
diagnoses for four
of the five
cancers detectable by screening: breast (from 47.8 % to 48.9 %) and cervical
cancer (47.3 % vs. 48.8 %, although this difference was not statistically significant) in women, and
lung (from 16.6 % to 17.7 %) and colorectal
cancer (22.8 % vs. 23.7 %) in men and women.
DENVER — Capturing and summarizing the remarkable progress in
lung cancer prevention, diagnosis, staging, and treatment in 2015, the International Association for the Study of Lung Cancer (IASLC) announces the inaugural publication of «Scientific Advances in Lung Cancer 2015» in the May 2016 issue of the IASLC's Journal of Thoracic Oncology (J
lung cancer prevention, diagnosis, staging, and treatment in 2015, the International Association for the Study of Lung Cancer (IASLC) announces the inaugural publication of «Scientific Advances in Lung Cancer 2015» in the May 2016 issue of the IASLC's Journal of Thoracic Oncology
cancer prevention,
diagnosis,
staging, and treatment in 2015, the International Association for the Study
of Lung Cancer (IASLC) announces the inaugural publication of «Scientific Advances in Lung Cancer 2015» in the May 2016 issue of the IASLC's Journal of Thoracic Oncology (J
Lung Cancer (IASLC) announces the inaugural publication of «Scientific Advances in Lung Cancer 2015» in the May 2016 issue of the IASLC's Journal of Thoracic Oncology
Cancer (IASLC) announces the inaugural publication
of «Scientific Advances in
Lung Cancer 2015» in the May 2016 issue of the IASLC's Journal of Thoracic Oncology (J
Lung Cancer 2015» in the May 2016 issue of the IASLC's Journal of Thoracic Oncology
Cancer 2015» in the May 2016 issue
of the IASLC's Journal
of Thoracic Oncology (JTO).
We reviewed 10 observational studies, all
of which showed some evidence that people who continue to smoke after a
diagnosis of early
stage lung cancer have an associated higher risk
of recurrence, second primary tumour, or all cause mortality compared with those who stop smoking at that time.
Lung cancer is the leading cause
of cancer mortality worldwide, suffering from a late
stage of disease at the time
of diagnosis and a paucity
of effective therapeutic strategies to treat advanced tumours.